Results 121 to 130 of about 4,128,106 (288)

Association Between Neurofilament Light Chain and Real‐World Ambulatory Function in Progressive MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurofilament light chain (NfL) is a biomarker of neuroaxonal injury in multiple sclerosis (MS), yet associations with functional outcomes remain unclear. Longitudinal associations between serum NfL (sNfL) and daily step count (STEPS) from wearable devices were assessed in a large international progressive MS cohort.
Gabby B. Joseph   +5 more
wiley   +1 more source

The cost of drugs [PDF]

open access: yesCanadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2017
openaire   +2 more sources

The development impact of the illegality of drug trade [PDF]

open access: yes
This paper reviews the unintended consequences of the war on drugs, particularly for developing countries, and weighs them against the evidence regarding the efficacy of prohibition to curb drug use and trade.
Keefer, Philip   +2 more
core  

Direct medical costs for drug-resistant tuberculosis inpatients at the national lung hospital, Vietnam: A one-year study

open access: yesJournal of Public Health Research
Drug-resistant tuberculosis remains a major global public health challenge due to its complex treatment regimens and prolonged treatment duration. Drug-resistant tuberculosis treatment requires more expensive second-line medications, intensive monitoring,
Do Minh Ngo   +3 more
doaj   +1 more source

Subjective Cognitive Concerns and Cognitive Trajectories in Parkinson's Disease: Biomarker Impact

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the relationship of subjective cognitive concerns (SCC) with biomarkers of Alzheimer's disease (AD), neurodegeneration, and Parkinson's disease (PD) and domain‐specific cognitive trajectories among cognitively unimpaired persons with de novo PD. Method Cognitively unimpaired participants with SCC (n = 294) and without SCC (
Francesca V. Lopez   +5 more
wiley   +1 more source

Hospitalization costs for cervical cancer patients in three tertiary hospitals in northern China, 2013 – 2022: degree of structural variation and gray relational analysis

open access: yesZhongguo gonggong weisheng
ObjectiveTo understand the structural variation in hospitalization costs for patients with cervical cancer and to investigate the reasons for these variations.
Mengting WANG   +9 more
doaj   +1 more source

Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act. [PDF]

open access: yesJ Am Coll Cardiol, 2023
Narasimmaraj PR   +7 more
europepmc   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

Home - About - Disclaimer - Privacy